Biosimilar - Legal and Regulatory Issues.pdfVIP

  • 7
  • 0
  • 约 16页
  • 2016-02-03 发布于浙江
  • 举报
Biosimilar - Legal and Regulatory Issues

Biosimilar - Legal and Regulatory Issues Shaoyu Chen Partner Covington Burling LLP Beijing Shanghai Offices, China 6th DIA China Annual Conference, May 14, 2014 Biosimilars in the EU • 2003: approval framework • 2006: approved two biosimilar somatropin • 2007-2013: approved 10+ biosimilars (EPO, Filgrastim) U.S. And Other Countries

文档评论(0)

1亿VIP精品文档

相关文档